ADELAIDE, Australia, June 3, 2020 /PRNewswire/ -- Toni Nesci has been appointed Head of Mayne Contract Services, a division of the Mayne Pharma family. Mayne Contract Services, based in Salisbury, South Australia is the full-service pharmaceutical development and manufacturing business unit created to serve clients worldwide by leveraging more than 40 years of scientific expertise in developing complex oral and topical dose forms.
Mayne Pharma President of International Operations Stefan Cross said, "Toni's appointment comes as the Company is experiencing strong growth in new clients and projects. Mayne Pharma has a long-standing reputation for world class product development and leadership, and we will continue to deliver on those promises for our clients."
Toni has over 20 years of pharmaceutical industry experience across strategy, business development, project management and new product launch. She has held a variety of roles at Pfizer and Hospira and most recently supported the successful launch of several US and global products at Pfizer. Educated in Adelaide, Mayne Pharma is delighted to return Toni's global industry experience to South Australia.
The Company launched a new website this week for Mayne Contract Services (www.maynecontractservices.com) showcasing the development and manufacturing capabilities of the Salisbury, South Australia facility.
About Mayne Contract Services
Mayne Contract Services is the full-service pharmaceutical development and manufacturing business unit serving clients worldwide with more than 40 years of scientific expertise in developing complex oral and topical dose forms including modified-release products, poorly soluble compounds and highly potent compounds.
Mayne Contract Services areas of expertise include quality pharmaceutical formulation development, first-time-in-man formulations; Phase I-III clinical trial manufacturing; and analytical method development and validation services leading to commercial scale manufacturing. Located in Salisbury, South Australia, Mayne Contract Services is a proud member of Mayne Pharma. Learn more at www.maynecontractservices.com.au
About Mayne Pharma
Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialise branded and generic pharmaceuticals, offering patients better and more accessible medicines. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.
Mayne Pharma has a 40-year track record of innovation and success in developing new oral drug delivery systems and these technologies have been successfully commercialised in numerous products that continue to be marketed around the world.
Mayne Pharma has two facilities based in Salisbury, Australia and Greenville, USA with expertise in the formulation of complex oral and topical dose forms including potent compounds, modified-release products and poorly soluble compounds.